StockData
Citius Oncology, Inc. logo

Citius Oncology, Inc. (CTOR) stock

CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.56+0.01 (+1.79%)

Close on Nov 18, 2026Market cap $51.83MP/E –Yield –

Citius Oncology pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Citius Oncology's pe ratio was 209.0× on Oct 31, 2025, against 141.5× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Oct 31, 2025209.0×+71.7
2024Dec 31, 2024137.4×–

More Citius Oncology figures

See a number that looks wrong?